Company Search:
Advanced Search
Sponsored Links
Miraca Holdings Incorporated Company Snapshot
Miraca Holdings Incorporated operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Miraca Holdings Incorporated with three other pharmaceutical manufacturers in Asia: BML Inc (2016 sales of 109.02 billion Japanese Yen [US$981.22 million] of which 95% was Testing business), Falco Holdings Co Ltd (48.73 billion Japanese Yen [US$438.54 million] of which 59% was Medical Test), and Dr. Lal PathLabs Ltd which is based in India (7.91 billion Indian Rupees [US$120.91 million] ).

Sales Analysis. Miraca Holdings Incorporated reported sales of ¥211.74 billion (US$1.91 billion) for the fiscal year ending March of 2016. This represents an increase of 3.5% versus 2015, when the company's sales were ¥204.67 billion. Sales at Miraca Holdings Incorporated have increased during each of the previous five years (and since 2011, sales have increased a total of 28%). Sales of Clinical Medical Check saw an increase of 5.4% in 2016, from ¥43.46 billion to ¥45.79 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Miraca Holdings Incorporated
  Stock Performance Chart for Miraca Holdings Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 5,360.00
(Figures in Japanese Yen)
1 Week -1.5%   13 Weeks 1.7%  
4 Weeks 4.5%   52 Weeks 13.0%  
Miraca Holdings Incorporated Key Data:
  Ticker: 4544 Country: Japan
  Exchanges: TYO Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2016 Sales 211,743,000,000
(Year Ending Jan 2017).
Employees: 6,129
  Currency: Japanese Yen Market Cap: 305,606,858,800
  Fiscal Yr Ends: March Shares Outstanding: 57,016,205
  Share Type: Common Closely Held Shares: 704,626
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.